● Covered by 1 source · 1 reportLow impact1 neutral
Abbott and Google Health Partner for AI-Powered Glucose Monitoring with Lingo CGM
Key points
- Abbott partners with Google Health for Lingo CGM integration.
- Lingo data will be accessible in Google Health app and Coach.
- AI-driven recommendations for lifestyle and nutrition choices.
- Lingo is intended for non-insulin-using adults.
- Companies will conduct a large metabolic health study.
Abbott and Google Health Collaboration
Abbott has announced a multi-year partnership with Google Health to connect its Lingo continuous glucose monitor (CGM) to the Google Health app. This integration will allow users of the over-the-counter Lingo device to view their metabolic data within the Google Health platform. The partnership aims to provide users with insights that could inform lifestyle and nutrition decisions.
AI-Powered Recommendations
The Lingo data will also be shareable with the Google Health Coach, which utilizes AI to offer personalized recommendations based on an individual's information. This feature is designed to translate glucose monitoring data into actionable advice for users.
Lingo Device and Target Audience
The Lingo CGM is specifically designed for adults who do not use insulin. This targets a non-diabetic population interested in tracking blood sugar levels for general health and wellness purposes. Previous reports have noted a trend of non-diabetics using CGMs, though research on the benefits for this group has been limited.
Uncertain Benefits for Non-Diabetics
Existing research, including an article from the Johns Hopkins Bloomberg School of Public Health, indicates that the health benefits of CGM use for non-diabetics are not clearly established. While tracking glucose might encourage better dietary choices, an overemphasis on blood sugar levels could potentially lead to unhealthy eating habits. Medical professionals also highlight the difficulty for laypersons to accurately interpret CGM results without additional medical context.
Future Research and Insights
As part of their agreement, Abbott and Google Health will conduct a large-scale real-world metabolic health study. This study will integrate continuous glucose, wearable, laboratory, and survey data to explore connections between activity, sleep, well-being, and metabolic health. The goal is to generate more personalized guidance to support healthier daily decisions, potentially shedding light on the utility of CGMs for non-diabetic populations.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
The daily brief
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Today's brief
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's brief
New every morning, and the back catalogue is archived by date.
Reporting from
Abbott has partnered with Google Health to integrate its Lingo continuous glucose monitor (CGM) data into the Google Health app, offering AI-driven recommendations for non-diabetic users. This collaboration aims to help individuals make lifestyle and nutrition choices based on their metabolic data, despite existing research indicating limited proven benefits of CGM use for non-diabetics.